Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Esther Aurensanz‐Clemente"'
Autor:
Esther Aurensanz‐Clemente, Álex Pérez Casares, Juan Pablo Muñoz, Patricia García‐Canadilla, Flavio Zuccarino, Joan Sanchez‐de‐Toledo
Publikováno v:
ESC Heart Failure, Vol 10, Iss 3, Pp 2090-2093 (2023)
Abstract Immunotherapy has considerably improved clinical outcomes in different types of cancers but has also been associated with the development of myocarditis, especially with that mediated by immune checkpoint inhibitors. To the best of our knowl
Externí odkaz:
https://doaj.org/article/d3199bdc5db34d0d9c4807bdb82986c6
Autor:
Patricia Garcia-Canadilla, Alba Isabel-Roquero, Esther Aurensanz-Clemente, Arnau Valls-Esteve, Francesca Aina Miguel, Daniel Ormazabal, Floren Llanos, Joan Sanchez-de-Toledo
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
Pediatric congenital heart disease (CHD) patients are at higher risk of postoperative complications and clinical deterioration either due to their underlying pathology or due to the cardiac surgery, contributing significantly to mortality, morbidity,
Externí odkaz:
https://doaj.org/article/dacc2eec44aa4ee2b12b4bf16e7f6751
Autor:
Esther Aurensanz Clemente, Mònica Boada Farràs, Andrés Fernando Almario-Hernández, Joan Sanchez-de-Toledo
Publikováno v:
Anales de Pediatría, Vol 93, Iss 3, Pp 208-210 (2020)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73921f62fd11bec2cdfa0248f2995bf5
https://doi.org/10.1016/j.anpedi.2019.08.008
https://doi.org/10.1016/j.anpedi.2019.08.008
Autor:
Joan Sanchez de Toledo, Jose M Caffarena Calvar, Alex Pérez Casares, Pablo Ruiz Frontera, Esther Aurensanz Clemente
Publikováno v:
Pediatric cardiology. 42(6)
Right ventricular (RV) dilatation is the determining prognostic factor in the long-term follow up of patients with repaired Tetralogy of Fallot (TOF). The objective of this study is to analyze whether the results vary depending on the timing of the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e62b81a8f1e19c2372ff4f992a522093
https://pubmed.ncbi.nlm.nih.gov/33934202
https://pubmed.ncbi.nlm.nih.gov/33934202
Autor:
Gloria Bueno Lozano, Luis Alberto Moreno Aznar, Ariadna Ayerza Casas, Olga Bueno Lozano, Pilar Samper Villagrasa, Pablo Ruiz Frontera, Esther Aurensanz Clemente
Publikováno v:
Anales de Pediatría (English Edition), Vol 86, Iss 5, Pp 240-248 (2017)
Introduction and objectives: Small for gestational age (SGA) children without catch-up growth can benefit from treatment with growth hormone (rhGH). However, they should be monitored very closely because they are at increased risk of metabolic syndro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6828e3f62e11b763c1f954d44afeca42
https://doi.org/10.1016/j.anpede.2016.05.005
https://doi.org/10.1016/j.anpede.2016.05.005
Autor:
Esther Aurensanz Clemente, Luis Alberto Moreno Aznar, Gloria Bueno Lozano, Olga Bueno Lozano, Ariadna Ayerza Casas, Pablo Ruiz Frontera, Pilar Samper Villagrasa
Publikováno v:
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Anales de Pediatría, Vol 86, Iss 5, Pp 240-248 (2017)
instname
Anales de Pediatría, Vol 86, Iss 5, Pp 240-248 (2017)
Introducción Los niños pequeños para la edad gestacional (PEG) sin crecimiento recuperador pueden beneficiarse del tratamiento con hormona de crecimiento (rhGH). Sin embargo, deben ser monitorizados de forma muy estrecha ya que son población de r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acebacf25a9e846661cd3b75dcd66b62
https://doi.org/10.1016/j.anpedi.2016.05.001
https://doi.org/10.1016/j.anpedi.2016.05.001
Autor:
Esther Aurensanz Clemente, Ariadna Ayerza Casas, Gloria Bueno Lozano, Pilar Samper Villagrasa, Pablo Ruiz Frontera
Publikováno v:
Medicina Clínica. 148:101-106
Resumen Introduccion y objetivos Los pacientes pequenos para la edad gestacional (PEG) son poblacion de riesgo para el desarrollo de enfermedad cardiovascular y sindrome metabolico. Nuestro objetivo es estudiar la morfologia y la funcion cardiaca en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efada415f4c3eddf15cde052956f3e12
https://doi.org/10.1016/j.medcli.2016.09.042
https://doi.org/10.1016/j.medcli.2016.09.042
Autor:
Juana Pelegrín Díaz, Lorenzo Montserrat Iglesias, Ariadna Ayerza Casas, Esther Aurensanz Clemente, Cecilia García Lasheras, Feliciano Jesús Ramos Fuentes, Inés Bueno Martínez, Pablo Ruiz Frontera
Publikováno v:
Clinical Case Reports
Key Clinical Message We think that the main interests of this study are the report of a new mutation in gene MYBPC3 as a cause of Hypertrophic cardiomyopathy (HMC), and the verification of the fact that not always is the number of mutations related t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c804ae18eccc8af82b059e067e42b4f
https://doi.org/10.1002/ccr3.832
https://doi.org/10.1002/ccr3.832
Autor:
Andrés Fernando, Almario-Hernández, Mònica, Boada Farràs, Esther, Aurensanz Clemente, Joan, Sanchez-de-Toledo
Publikováno v:
Anales de pediatria. 93(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::53396c062f2a43560d72bf12c935996f
https://pubmed.ncbi.nlm.nih.gov/31866233
https://pubmed.ncbi.nlm.nih.gov/31866233
Autor:
Ariadna Ayerza Casas, Gloria Bueno Lozano, Pablo Ruiz Frontera, Pilar Samper Villagrasa, Luis Alberto Moreno Aznar, Esther Aurensanz Clemente
Publikováno v:
Medicina Clínica. 147:231-237
Resumen Antecedentes y objetivos Los ninos pequenos para la edad gestacional (PEG) constituyen un grupo de riesgo para desarrollar sindrome metabolico. El objetivo de este estudio es evaluar las modificaciones que produce el tratamiento con growth ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7428a691b363373d7ca074d5833487d7
https://doi.org/10.1016/j.medcli.2016.06.002
https://doi.org/10.1016/j.medcli.2016.06.002